Concurrent epiphyseal fracture and leukemia in a patient treated with growth hormone.
Magnavita
N
N
Sica
S
S
Di Mario
A
A
Leone
G
G
D000293:Adolescent; D004393:Dwarfism, Pituitary / Q000150:complications / Q000188:drug therapy; D004838:Epiphyses / Q000293:injuries; D005598:Fractures, Spontaneous / Q000139:chemically induced*; D013006:Growth Hormone / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D008297:Male; D014411:Neoplastic Stem Cells / Q000187:drug effects; D010010:Osteoclasts / Q000187:drug effects; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000139:chemically induced*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000139:chemically induced*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D012008:Recurrence; D013978:Tibial Fractures / Q000139:chemically induced*
D011994:Recombinant Proteins; D013006:Growth Hormone